Durability of the Prostatic Urethral Lift: 2‐Year Results of the L.I.F.T. Study

[1]  H. Woo,et al.  Multicentre prospective crossover study of the ‘prostatic urethral lift’ for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia , 2014, BJU international.

[2]  F. Bruyère,et al.  Long-Term Outcomes of 80-Watt KTP and 120-Watt HPS GreenLight Photoselective Vaporization of the Prostate , 2014, Urologia Internationalis.

[3]  N. Shore,et al.  Prospective multi-center study elucidating patient experience after prostatic urethral lift. , 2014, The Canadian journal of urology.

[4]  C. Roehrborn,et al.  Treatment of LUTS secondary to BPH while preserving sexual function: randomized controlled study of prostatic urethral lift. , 2014, The journal of sexual medicine.

[5]  H. Woo,et al.  Minimally invasive prostatic urethral lift: surgical technique and multinational experience. , 2013, European urology.

[6]  J. J. de la Rosette,et al.  Midterm results from an international multicentre randomised controlled trial comparing bipolar with monopolar transurethral resection of the prostate. , 2013, European urology.

[7]  H. Woo,et al.  Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. , 2012, European Urology.

[8]  C. Roehrborn,et al.  Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. , 2012, Urology.

[9]  Y. Ilbey,et al.  120-W GreenLight laser photoselective vaporization of prostate for benign prostatic hyperplasia: midterm outcomes. , 2011, Urology.

[10]  C. Roehrborn,et al.  Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) , 2011, BJU international.

[11]  John T. Wei,et al.  Update on AUA guideline on the management of benign prostatic hyperplasia. , 2011, The Journal of urology.

[12]  A. Shokeir,et al.  441 GREENLIGHT HPS 120-W LASER VAPORIZATION VERSUS TRANSURETHRAL RESECTION OF THE PROSTATE FOR TREATMENT OF BENIGN PROSTATIC HYPERPLASIA: A RANDOMIZED CLINICAL TRIAL WITH MID TERM FOLLOW-UP , 2011 .

[13]  A. Al-Ansari,et al.  GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. , 2010, European urology.

[14]  H. Woo,et al.  1904 120W GREENLIGHT LASER PROSTATECTOMY – ONE YEAR DATA FROM AN ONGOING PROSPECTIVE MULTICENTRE STUDY (INTERNATIONAL GREENLIGHT USERS GROUP - IGLU) , 2010 .

[15]  A. Bachmann,et al.  Complications of laser prostatectomy: a review of recent data , 2010, World Journal of Urology.

[16]  M. Hai.  Photoselective vaporization of prostate: five-year outcomes of entire clinic patient population. , 2009, Urology.

[17]  T. Gasser,et al.  Comparison of potassium‐titanyl‐phosphate laser vaporization of the prostate and transurethral resection of the prostate: update of a prospective non‐randomized two‐centre study , 2008, BJU international.

[18]  T. Gasser,et al.  GreenLight laser vaporization of the prostate: single-center experience and long-term results after 500 procedures. , 2008, European urology.

[19]  A. Skolarikos,et al.  Transurethral photoselective vaporization versus transvesical open enucleation for prostatic adenomas >80ml: 12-mo results of a randomized prospective study. , 2008, European urology.

[20]  K. Sarıca,et al.  Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70 mL: a short-term prospective randomized trial. , 2008, Urology.

[21]  C. Roehrborn.  Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations. , 2008, Reviews in urology.

[22]  T. Wilt,et al.  Microwave thermotherapy for benign prostatic hyperplasia. , 2007, The Cochrane database of systematic reviews.

[23]  Scott Van Appledorn,et al.  KTP laser versus transurethral resection: early results of a randomized trial. , 2006, Journal of endourology.

[24]  C. Bouza,et al.  Systematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia , 2006, BMC urology.

[25]  S. Madersbacher,et al.  Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. , 2005, European urology.

[26]  B. Stricker,et al.  Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project. , 2003, European urology.

[27]  R. Bruskewitz,et al.  Maximum urinary flow rate by uroflowmetry: automatic or visual interpretation. , 1993, The Journal of urology.

[28]  K McPherson,et al.  Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. , 1989, The New England journal of medicine.